ResMed logoResMed

(NYSE:RMD)

 this week announced it appointed two new executives to its C-suite.

Michael Rider was appointed as global general counsel and secretary, effective July 1. Dawn Haake was appointed to serve as ResMed’s first chief quality officer, effective May 1. Both were internal promotions and joined the executive team on May 1.

Rider will remain in his current role as senior VP and deputy global general counsel until July 1, when he will succeed current chief administrative officer and global general counsel David Pendarvis, who is retiring on June 30. Rider previously joined the company in 2012 as VP and general counsel of the Americas region and was named deputy global general counsel in 2019. He has more than 40 years of legal experience, including as senior vice president, general counsel for Callaway Golf, senior attorney for American Airlines and associate attorney at Gibson Dunn & Crutcher.

Haake was promoted from VP of quality assurance and regulatory affairs. She joined ResMed in 2015 as VP of quality assurance and added VP of regulatory affairs to her title in 2017. She has more than 30 years of experience in the medtech industry. Haake was previously the senior director of global quality assurance at NuVasive, senior specialist of quality assurance at Nellcor Puritan Bennett (now a part of Medtronic) and a tech supply administrator at Infrasonics.

“Mike and Dawn are both longtime industry experts, celebrated team leaders, and relentless drivers of ResMed’s culture of excellence, always putting the health, safety, and wellbeing of patients, providers, and our employees first,” CEO Mick Farrell said in a news release. “I’m excited to have them both join ResMed’s executive team. Their internal promotions into these critical roles demonstrate ResMed’s deep bench strength across the organization, enabling us to reach our goal of helping 250 million people sleep, breathe, and live healthier lives in 2025.”

The appointments follow ResMed’s announcement last month that it appointed Amy Wakeham as the company’s first chief communications and investor relations officer.